Third. by Cuicui Liu (1496260)

Validation of child labor measures using third-party data, households with all children in school. by Guilherme Lichand (11410286)

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Effect of anti-<i>Leishmania</i> drugs added to a sugar diet on the longevity of <i>Lu. longipalpis</i> females. by Tainá Neves Ferreira (21601579)

Effect of anti-<i>Leishmania</i> drugs added to a sugar diet on the longevity of <i>Lu. longipalpis</i> males. by Tainá Neves Ferreira (21601579)

Effect of anti-<i>Leishmania</i> compounds added to a sugar diet on females of <i>Lu. longipalpis</i> pre and post-blood feeding. by Tainá Neves Ferreira (21601579)

Number of consultations (%) during each lockdown period compared to a control period (one year before for the first and second lockdown, and two years before for the third lockdown... by Luther Dogbla (21410142)

Prevalence of consultations (%) during each lockdown compared to a control period (one year before for the first and second lockdown, and two years before for the third lockdown),... by Luther Dogbla (21410142)

Effect of anti-<i>Leishmania</i> compounds on fecundity of females and egg fertility. by Tainá Neves Ferreira (21601579)

Quantification of ingested proteins by females after 30 minutes of blood feeding. by Tainá Neves Ferreira (21601579)

Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. by Nadia Gul (249538)

Measurement of the mortality rate of RPW third and fifth instar larvae after three and six days of exposure to three different dsRNAs. by Muhammad Naeem Sattar (19828497)

Change^a in incidence of repetition according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Change^a in incidence of dropout according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”